Treysta Medical Techologies Inc.
Developer of preventative scar-reduction therapies and a regenerative platform for serious burn care. The organization is developing a topical therapeutic intended for acute postoperative use to reduce scarring and a modular treatment system aimed at improving aesthetic and functional outcomes after severe burns. The team emphasizes regulated product development, quality systems, and designs intended for use across diverse and resource-constrained environments.
Industries
Nr. of Employees
small (1-50)
Treysta Medical Techologies Inc.
Gainesville, Florida, United States, North America
Products
Topical scar-prevention ointment for acute postoperative use
A topical formulation intended to be applied during the first week of recovery after surgery to interrupt scarring pathways and promote healing that more closely resembles normal skin.
Modular regenerative burn-treatment system
A platform designed for early treatment of second- and third-degree burns to reduce scarring, fibrosis, and contracture and to improve aesthetic and functional outcomes during the first two to four weeks of care.
TreystaCare™ System
A treatment technology for the care of serious second and third degree burns, designed to be used in emergency settings and across the first two to four weeks of treatment to drastically improve aesthetic and functional healing outcomes by reducing scarring, fibrosis, and contracture.
Topical scar-prevention ointment for acute postoperative use
A topical formulation intended to be applied during the first week of recovery after surgery to interrupt scarring pathways and promote healing that more closely resembles normal skin.
Modular regenerative burn-treatment system
A platform designed for early treatment of second- and third-degree burns to reduce scarring, fibrosis, and contracture and to improve aesthetic and functional outcomes during the first two to four weeks of care.
TreystaCare™ System
A treatment technology for the care of serious second and third degree burns, designed to be used in emergency settings and across the first two to four weeks of treatment to drastically improve aesthetic and functional healing outcomes by reducing scarring, fibrosis, and contracture.
Expertise Areas
- Scar-prevention therapeutics
- Regenerative therapeutics for burn care
- Perioperative wound-care integration
- Regulatory quality systems and cGMP processes
Key Technologies
- Topical drug delivery for wound applications
- Regenerative medicine therapeutic platforms
- Wound-care workflow integration
- Modular portable treatment system design